Jenburkt Pharmaceuticals (JENBURPH) Share Price near 52-week low as stock stays weak

Jenburkt Pharmaceuticals Share Price is trading at Rs 872, down 2.67% from the previous close of Rs 895.9, and the move places the stock near its 52-week low while the market capitalisation stands at Rs 395.39 crore. The latest Univest screen shows the price event clearly, but it does not establish a company-specific catalyst. That matters because the stock is drawing attention in stock market today searches, especially for investors tracking Jenburkt Pharmaceuticals Share Price Today, Jenburkt Pharmaceuticals Stock News and Jenburkt Pharmaceuticals Share Price Live.

The intraday setup shows selling pressure after an open of Rs 913.15 and a day high of Rs 913.15, before the stock moved to a low of Rs 867.5. In this context, Jenburkt Pharmaceuticals Share Price is being watched as a one-year low story rather than a momentum breakout. The move is also relevant because the company’s valuation and quality metrics look different from the wider Pharmaceuticals & Drugs basket, which keeps Jenburkt Pharmaceuticals Share News in focus for market participants looking at price action and fundamental analysis together.

Jenburkt Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 872
Previous Close	Rs 895.9
Today's Move	Rs -23.9 (-2.67%)
Open	Rs 913.15
High	Rs 913.15
Low	Rs 867.5
Market Capitalisation	Rs 395.39 crore

Jenburkt Pharmaceuticals Ltd. (JENBURPH) traded at Rs 872 versus the previous close of Rs 895.9, a fall of 2.67%. The stock opened at Rs 913.15, reached a high of Rs 913.15, touched a low of Rs 867.5.

Jenburkt Pharmaceuticals Share Price Today reflects a sharp intraday shift from the day’s opening level of Rs 913.15 to the current Rs 872. The stock had a previous close of Rs 895.9, so the decline of Rs 23.9 or 2.67% shows that sellers stayed in control through the morning trade. The day’s range between Rs 867.5 and Rs 913.15 also shows a wider swing than the current price suggests, which is why Jenburkt Pharmaceuticals Share Price is being discussed among Stocks in News and Top Losers Today watchers.

For investors tracking Jenburkt Pharmaceuticals Stock News, the key point is that the current price is very close to its 52-week low area, and the stock remains in the conversation around 52 Week Low Stocks and Stocks at 52 Week Low. The event is meaningful because the latest price action shows weakness without any confirmed company-specific trigger. In simple terms, Jenburkt Pharmaceuticals Share Price has weakened into a support zone, and that keeps the next price reaction important for anyone following Jenburkt Pharmaceuticals Share Price Update or Jenburkt Pharmaceuticals Share Price Today.

Jenburkt Pharmaceuticals Ltd. (JENBURPH) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 395.39 crore
P/E Ratio	12.04x
P/B Ratio	1.95x
ROE	18.84%
ROCE	25.34%
EPS	Rs 74.39
Book Value Per Share	Rs 459.8
Dividend Yield	2.31%

Jenburkt Pharmaceuticals Ltd. (JENBURPH) fundamental metrics show P/E 12.04x, P/B 1.95x, ROE 18.84%, ROCE 25.34%. These figures provide context only and are not a buy or sell signal.

Jenburkt Pharmaceuticals Ltd. has a market capitalisation of Rs 395.39 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 12.04x, P/B at 1.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.84% and ROCE of 25.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 74.39, book value per share of Rs 459.8, dividend yield of 2.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.02x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	12.04x
Benchmark Median P/E	27.02x
Benchmark Average P/E	38.91x
Benchmark P/E Range	0x to 616.23x
Company P/B Ratio	1.95x
Benchmark Median P/B	2.7x
Company ROE	18.84%
Benchmark Median ROE	11.23%
Company ROCE	25.34%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 395.39 crore
Benchmark Median Market Cap	Rs 786.06 crore

Jenburkt Pharmaceuticals Ltd. (JENBURPH) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a P/E ratio of 12.04x, which is below the benchmark median of 27.02x, a difference of -55.44%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a ROE of 18.84%, which is above the benchmark median of 11.23%, a difference of +67.76%. Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a ROCE of 25.34%, which is above the benchmark median of 13.17%, a difference of +92.41%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Medicamen Biotech Ltd.	MEDICAMEQ	369.79	33.02	1.32	3.23	5.77
Albert David Ltd.	ALBERTDAVD	437.54	19.39	1.03	-0.38	0.83
SMS Lifesciences India Ltd.	HALEOSLABS	458.8	30.74	2.26	8.68	10.53
Astonea Labs Ltd.	ASTONEALAB	339.51	75.19	5.94	11.95	10.51
Trident Lifeline Ltd.	TLL	481.64	24.41	4.69	18.78	19.17

Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a P/E ratio of 12.04x compared with the displayed peer median of 30.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.84% compares with a peer median of 8.68% across the companies shown in the table. ROCE stood at 25.34% versus the displayed peer median of 10.51%, providing a capital-efficiency comparison. Jenburkt Pharmaceuticals Ltd. (JENBURPH) has a market capitalisation of Rs 395.39 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Jenburkt Pharmaceuticals

• Jenburkt Pharmaceuticals Share Price is trading near its yearly low, keeping the stock on the radar of 52 Week Low Stocks watchers.
• The day move of 2.67% lower shows weak price action, with the low at Rs 867.5 near the current level.
• Jenburkt Pharmaceuticals Technical Analysis points to a weak short-term setup, with RSI at 33.12 and the price below the 50 DMA of Rs 942.55 and 200 DMA of Rs 1,046.86.
• Jenburkt Pharmaceuticals Fundamental Analysis shows a low P/E of 12.04, strong ROE of 18.84% and ROCE of 25.34%, which gives the stock a distinct valuation profile.
• The Healthcare sector comparison and peer view keep Jenburkt Pharmaceuticals Share Price in focus for relative-value tracking.

About Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s business context, as reflected in the available market data, is tied to pharmaceuticals and healthcare-related products rather than a broad diversified industrial mix. That makes Jenburkt Pharmaceuticals Share Price sensitive to both company-specific earnings execution and wider healthcare sentiment.

At a market cap of Rs 395.39 crore, the company sits in a smaller listed bracket compared with many industry peers, yet its return ratios remain notable. The latest revenue figure of Rs 35.51 crore for Jun 2026 adds operational context to Jenburkt Pharmaceuticals Stock News, while EPS of 74.39, book value of Rs 459.8 and dividend yield of 2.31 give investors concrete financial markers for Jenburkt Pharmaceuticals Share Price analysis. In practical terms, the stock is being followed as a healthcare name where valuation, returns and price weakness are all visible in the same snapshot.

Track Jenburkt Pharmaceuticals Share Price on Univest

Use Jenburkt Pharmaceuticals Ltd. (JENBURPH) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Investors can track Jenburkt Pharmaceuticals Share Price on Univest for live price updates, 52-week levels, technical indicators, valuation ratios, shareholding pattern, sector comparison and market insights. Univest brings the key parts of Jenburkt Pharmaceuticals Stock Analysis together in one place, making it easier to follow Jenburkt Pharmaceuticals Share Price Today, Jenburkt Pharmaceuticals Latest News and the company’s broader market context.

For anyone scanning Jenburkt Pharmaceuticals Stock News or Jenburkt Pharmaceuticals Share News, Univest also helps connect the price move with fundamentals such as P/E, P/B, ROE, ROCE, EPS and book value. That keeps the focus on verified data while the stock trades near a 52-week low.

Frequently Asked Questions

Why is Jenburkt Pharmaceuticals Share Price falling today?

Ans. Jenburkt Pharmaceuticals Share Price is down 2.67% to Rs 872 from Rs 895.9, but the latest Univest data does not establish a company-specific catalyst. The move reflects intraday selling pressure and a near 52-week low setup.

What is Jenburkt Pharmaceuticals Share Price today?

Ans. Jenburkt Pharmaceuticals Share Price today is Rs 872. It traded between Rs 867.5 and Rs 913.15 during the current move, while the market capitalisation stands at Rs 395.39 crore. The stock moved -2.67% during the session.

Is Jenburkt Pharmaceuticals trading near its 52-week low?

Ans. Yes, Jenburkt Pharmaceuticals Share Price is trading near its 52-week low and one-year low. The current level is close to the recent floor, which is why the stock is drawing attention in market screens.

How does Jenburkt Pharmaceuticals compare on valuation?

Ans. Jenburkt Pharmaceuticals Share Price trades at a P/E of 12.04 and P/B of 1.95, both below the industry medians of 27.02 and 2.7. That places the stock below the broader valuation range.

What do ROE and ROCE show for Jenburkt Pharmaceuticals?

Ans. ROE of 18.84% and ROCE of 25.34% indicate strong return generation relative to the sector benchmark. For Jenburkt Pharmaceuticals Share Price, those figures add quality context to the lower valuation.

How does Jenburkt Pharmaceuticals look versus peers?

Ans. Jenburkt Pharmaceuticals Share Price has a lower P/E than Medicamen Biotech, SMS Lifesciences India, Astonea Labs, Trident Lifeline and Ambalal Sarabhai Enterprises. Its ROE and ROCE are also stronger than most peers in the list.

What is the market cap of Jenburkt Pharmaceuticals?

Ans. Jenburkt Pharmaceuticals Share Price is supported by a market capitalisation of Rs 395.39 crore. That places it below the industry median market cap of Rs 786.06 crore in the same-industry benchmark.

Where can investors track Jenburkt Pharmaceuticals Share Price?

Ans. Investors can track Jenburkt Pharmaceuticals Share Price on Univest for live price updates, technical indicators, valuation ratios, shareholding pattern, 52-week levels and broader stock analysis in one place. The stock moved -2.67% during the session.